Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Eraslan, S, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2022, ' Long-term health consequences of COVID-19 in patients with Inflammatory Bowel Diseases-A Danish prospective population-based cohort study ', Journal of Crohn's and Colitis, vol. 16, no. Suppl. 1, pp. I073-I076 . https://doi.org/10.1093/ecco-jcc/jjab232.062
Attauabi, M, Dahlerup, J F, Poulsen, A, Hansen, M R, Vester-Andersen, M K, Eraslan, S, Prahm, A P, Pedersen, N, Larsen, L, Jess, T, Neumann, A, Haderslev, K V, Molazahi, A, Lødrup, A B, Glerup, H, Oppfeldt, A M, Jensen, M D, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2022, ' Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications-A Danish prospective population-based cohort study ', Journal of Crohn's & colitis, vol. 16, no. Suppl. 1, pp. I587-I588 . https://doi.org/10.1093/ecco-jcc/jjab232.807
Attauabi, M, Poulsen, A, Verner-Andersen, M K, Hansen, M R, Pedersen, N, Prahm, A P, Lødrup, A B, Haderselv, K, Larsen, L, Jess, T, Glerup, H, Molazahi, A, Oppfeldt, A M, Dahlerup, J F, Hvas, C L, Neumann, A, Wase, A, Jensen, M D, Nathan, T, Jensen, S, Theede, K, Kiszka-Kanowitz, M, Seidelin, J B, Burisch, J & the Danish COVID-IBD Study Group 2021, ' Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications-A Danish prospective population-based cohort study ', Journal of Crohn's & colitis, vol. 15, no. Suppl. 1, pp. S197-S197 . https://doi.org/10.1093/ecco-jcc/jjab076.230